Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):企業のM&A・事業提携・投資動向

◆英語タイトル:Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1441
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:97
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Munchener Ruckversicherungs-Gesellschaft AG (Munich Re)’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Munchener Ruckversicherungs-Gesellschaft AG (Munich Re). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Munchener Ruckversicherungs-Gesellschaft AG (Munich Re)’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) and its subsidiaries since 2007.
- Information about key financial and legal advisors for Munchener Ruckversicherungs-Gesellschaft AG (Munich Re)’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Munchener Ruckversicherungs-Gesellschaft AG (Munich Re)’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 52
Corporate Venturing – Overview 52
Corporate Venturing – Deal reports 53
PARTNERSHIP 61
Partnership – Overview 61
Partnership – Deal reports 62
DIVESTMENTS 67
Divestments – Overview 67
Divestments – Deal reports 68
PRIVATE EQUITY & OWNERSHIP 82
Private Equity and Ownership – Deal reports 82
APPENDIX 87
Contact Us 87
About MarketLine Financial Deals Database 87
Deal Definition and Methodology 89
About MarketLine 96

List of Tables
Table 1: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft M&A volume and value trend (2014-YTD2018)
Table 2: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft M&A activity by geography (2014-YTD2018)
Table 3: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft corporate venturing volume and value trend (2014-YTD2018)
Table 4: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft corporate venturing by geography (2014-YTD2018)
Table 5: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft partnership volume and value trend (2014-YTD2018)
Table 6: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft partnership trend by key deal type (2014-YTD2018)
Table 7: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft divestments volume and value trend (2014-YTD2018)
Table 8: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft M&A volume and value trend (2014-YTD2018)
Figure 2: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft M&A activity by geography (2014-YTD2018)
Figure 3: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft corporate venturing by geography (2014-YTD2018)
Figure 5: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft partnership volume and value trend (2014-YTD2018)
Figure 6: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft partnership trend by key deal type (2014-YTD2018)
Figure 7: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft divestments volume and value trend (2014-YTD2018)
Figure 8: Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft divestments by geography (2014-YTD2018)

★海外企業調査レポート[Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • High Energy Batteries (India) Ltd:企業の戦略・SWOT・財務分析
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Semcon AB (SEMC):企業の財務・戦略的SWOT分析
    Summary Semcon AB (Semcon) is a technology company that offers product design and information services. The company’s services include production development, project management, designing, product development, and product information. Its designing services comprise visualization, industrial design …
  • Oryx Petroleum Corp Ltd (OXC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oryx Petroleum Corp Ltd (Oryx Petroleum), a subsidiary of The Addax and Oryx Group Ltd, is an upstream company that explores oil and gas. The company explores, develops and produces natural resources. It holds interests in petroleum license areas in Africa and the Middle East. Oryx Petroleum …
  • Sime Darby Bhd (SIME):電力:M&Aディール及び事業提携情報
    Summary Sime Darby Bhd (Sime Darby) is a trading and logistics company. It provides diversified products and services through its subsidiaries, affiliates, and joint ventures. The company cultivates oil palm, rubber and sugarcane; rears cattle; and produces oil and fats. It also imports, assembles, …
  • Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Knight-Swift Transportation Holdings Inc. (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc. (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • AMTEC Corporation:企業の戦略・SWOT・財務情報
    AMTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary AMTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Korea Electric Power Corp (015760):電力:M&Aディール及び事業提携情報
    Summary Korea Electric Power Corp (KEPCO) is an integrated electric utility. It generates, transmits, and distributes electricity. The company produces electricity using nuclear, thermal, renewable, and other sources. Through power purchase agreements with independent power producers, KEPCO procures …
  • Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Oregon Health & Science University-製薬・医療分野:企業M&A・提携分析
    Summary Oregon Health & Science University (OHSU), a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center’s educational institute offers undergraduate and graduate courses in anesthesiology, derm …
  • Scotiabank Private Banking:企業の戦略・SWOT・財務分析
    Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ligand Pharmaceuticals Inc (LGND):製薬・医療:M&Aディール及び事業提携情報
    Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company employs research technologies including nuclear receptor assays, formulation science, high throughput computer screening, antibody discovery technologies an …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Elizabeth Arden, Inc.:企業の戦略的SWOT分析
    Elizabeth Arden, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆